RPF Sub-Inspector (Executive) 2024 · Question 413 of 640

In March 2023, India rejected Johnson and Johnson’s attempt to extend its monopoly on the manufacturing of which TB drug, invoking Section 3(d) of the Indian Patent Law?

Answer: C. Bedaquiline

Official answer key verified. Detailed explanation coming soon.

Source: RPF SI 2024 Question Paper All Shifts (English) — official response sheet via aglasem (green-tick correct answers) · official-answer-key

Practice the full RPF Sub-Inspector (Executive) 2024 paper

Timed test with all 640 questions, just like the real exam.